Expanding Facilities Actavis, now operating under Allergan, has historically invested in expanding its manufacturing capabilities, notably opening new facilities in Kansas City, Missouri. This indicates potential opportunities to offer equipment, infrastructure solutions, or manufacturing support services to support their ongoing growth or modernization efforts.

Innovative Product Launches Recent launches like TissuGlu Surgical Adhesive and JUVÉDERM VOLUX showcase Allergan's focus on advanced medical and aesthetic products. This suggests a demand for suppliers of raw materials, packaging innovations, and device technology that align with their new product categories.

Strategic Acquisitions Since being acquired by AbbVie in 2020, Allergan has integrated into a larger biopharmaceutical ecosystem, emphasizing a strategic repositioning. There may be opportunities to collaborate on R&D, manufacturing, or distribution channels in the rapidly evolving biopharma landscape.

Market Trend Leadership Allergan’s publication of the Future of Aesthetics Global Trends Report indicates an active engagement with defining industry standards and consumer preferences, opening avenues for market research, trend analysis services, and consumer insights collaborations.

Regulatory and Recall Management The global recall of BIOCELL textured breast implants highlights the importance of compliance and risk management systems. Companies offering quality assurance, regulatory consultancy, or recall management services could find strategic opportunities supporting Allergan’s safety and compliance initiatives.